Zoetis Inc. (NYSE:ZTS) Shares Purchased by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. grew its position in Zoetis Inc. (NYSE:ZTS) by 3.3% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 182,403 shares of the company’s stock after purchasing an additional 5,900 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Zoetis were worth $29,719,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the stock. New York Life Investment Management LLC grew its stake in shares of Zoetis by 0.5% in the fourth quarter. New York Life Investment Management LLC now owns 67,639 shares of the company’s stock worth $11,020,000 after acquiring an additional 335 shares during the last quarter. Walter Public Investments Inc. raised its position in shares of Zoetis by 10.2% in the 4th quarter. Walter Public Investments Inc. now owns 92,852 shares of the company’s stock valued at $15,128,000 after acquiring an additional 8,587 shares during the period. Heritage Investors Management Corp increased its stake in Zoetis by 3.5% during the 4th quarter. Heritage Investors Management Corp now owns 185,104 shares of the company’s stock worth $30,159,000 after purchasing an additional 6,337 shares in the last quarter. SRN Advisors LLC bought a new position in shares of Zoetis during the 4th quarter worth approximately $225,000. Finally, Checchi Capital Advisers LLC boosted its holdings in shares of Zoetis by 3.7% in the 4th quarter. Checchi Capital Advisers LLC now owns 3,122 shares of the company’s stock valued at $509,000 after buying an additional 110 shares during the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Barclays lifted their target price on Zoetis from $242.00 to $244.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. UBS Group started coverage on Zoetis in a research report on Monday, December 9th. They issued a “neutral” rating and a $196.00 target price on the stock. Morgan Stanley decreased their target price on Zoetis from $243.00 to $238.00 and set an “overweight” rating on the stock in a research report on Friday, February 14th. Piper Sandler reduced their price target on Zoetis from $210.00 to $200.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Finally, Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Two analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $215.40.

Zoetis Trading Down 2.1 %

NYSE ZTS opened at $164.99 on Thursday. The company has a market cap of $73.88 billion, a price-to-earnings ratio of 30.16, a P/E/G ratio of 2.78 and a beta of 0.90. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.53. The business has a 50 day moving average price of $166.22 and a 200-day moving average price of $177.58. The company has a quick ratio of 1.08, a current ratio of 1.75 and a debt-to-equity ratio of 1.09.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.37 by $0.03. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The firm had revenue of $2.32 billion during the quarter, compared to the consensus estimate of $2.30 billion. As a group, equities analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Investors of record on Monday, April 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, April 21st. This represents a $2.00 annualized dividend and a yield of 1.21%. Zoetis’s dividend payout ratio (DPR) is currently 36.56%.

Insider Buying and Selling

In related news, EVP Roxanne Lagano sold 326 shares of the company’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $171.18, for a total transaction of $55,804.68. Following the completion of the sale, the executive vice president now owns 16,107 shares in the company, valued at approximately $2,757,196.26. This represents a 1.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.16% of the stock is currently owned by corporate insiders.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.